• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金诺芬的药代动力学:人体单剂量研究

Pharmacokinetics of auranofin a single dose study in man.

作者信息

Benn H P, Schnier C, Seiler K U, Bauer E, Löffler H

机构信息

2nd Department of Internal Medicine, University of Kiel, West Germany.

出版信息

J Rheumatol. 1990 Apr;17(4):466-8.

PMID:2348424
Abstract

Three days after cholecystectomy 7 patients were given a single dose of auranofin (5 tablets Ridaura = 4.35 mg gold). Gold was detected in samples of blood, plasma, urine, bile and feces. The determinations were carried out using instrumental neutron activation analysis. The mean gold concentrations reached maximum in blood and plasma after 2 h and in urine and bile after 16 h. The mean terminal half-lives were 7.6 days (blood), 15 days (plasma) and 6.5 days (bile). Cumulative amounts of gold excreted in bile, urine, and feces were 1.6, 4 and 40%, respectively.

摘要

胆囊切除术后三天,给7名患者单次服用一剂金诺芬(5片瑞得 = 4.35毫克金)。在血液、血浆、尿液、胆汁和粪便样本中检测到了金。使用仪器中子活化分析法进行测定。血液和血浆中的平均金浓度在2小时后达到最高,尿液和胆汁中的平均金浓度在16小时后达到最高。平均终末半衰期分别为血液7.6天、血浆15天和胆汁6.5天。胆汁、尿液和粪便中排泄的金的累积量分别为1.6%、4%和40%。

相似文献

1
Pharmacokinetics of auranofin a single dose study in man.金诺芬的药代动力学:人体单剂量研究
J Rheumatol. 1990 Apr;17(4):466-8.
2
[Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].[通过仪器中子活化分析法对单剂量口服金诺芬后金在胆汁、肾脏及粪便中的排泄与分布进行定量分析]
Z Rheumatol. 1991 Jan-Feb;50(1):32-8.
3
Whole body elimination routes of gold in humans after a single-dose application of the antirheumatic auranofin.单次应用抗风湿药金诺芬后人体中金的全身消除途径。
Biol Trace Elem Res. 1990 Jul-Dec;26-27:471-7. doi: 10.1007/BF02992702.
4
Single dose pharmacokinetics of auranofin in rheumatoid arthritis.金诺芬在类风湿性关节炎中的单剂量药代动力学
J Rheumatol Suppl. 1982 Jul-Aug;8:110-9.
5
Pharmacokinetics of auranofin in animals.
J Rheumatol Suppl. 1982 Jul-Aug;8:90-8.
6
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
7
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.新型抗寄生虫药金诺芬的I期临床试验结果
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01947-16. Print 2017 Jan.
8
Pharmacokinetics of gold sodium thiomalate.硫代苹果酸金钠的药代动力学
Res Commun Chem Pathol Pharmacol. 1982 Jul;37(1):33-47.
9
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.新型促甲状腺素释放激素类似物水合蒙替瑞林的药代动力学。首次通讯:对大鼠、狗和猴子单次静脉给药后的血浆浓度、代谢及排泄情况
Arzneimittelforschung. 1996 Feb;46(2):106-13.
10
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.新型促甲状腺素释放激素类似物水合蒙特瑞林的药代动力学。第二篇通讯:单次静脉给药后在胎体和乳汁中的分布与转运以及对大鼠重复静脉给药后的药代动力学和酶诱导作用
Arzneimittelforschung. 1996 Feb;46(2):114-27.

引用本文的文献

1
Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.人头颈癌细胞对谷胱甘肽和硫氧还蛋白代谢联合抑制的敏感性。
PLoS One. 2012;7(10):e48175. doi: 10.1371/journal.pone.0048175. Epub 2012 Oct 31.
2
Clinical pharmacokinetics of slow-acting antirheumatic drugs.慢作用抗风湿药物的临床药代动力学
Clin Pharmacokinet. 1993 Nov;25(5):392-407. doi: 10.2165/00003088-199325050-00005.